BioSpace News Archive

InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol, will report financial results for the second quarter of fiscal year 2021 ending December 31, 2020, on Thursday, February 11, 2021.

BIOLASE, Inc., the global leader in dental lasers, announced that it has entered into an underwriting agreement with Maxim Group LLC under which the underwriters have agreed to purchase, on a firm commitment basis, 14,000,000 shares of common stock of the Company, at a price to the public of $1.03 per share less underwriting discounts and commissions.